(COFB) Cofinimmo - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003593044
COFB: Healthcare Properties, Residential Properties, Office Spaces
Cofinimmo SA (BR:COFB) is a leading European real estate investment trust (REIT) specializing in healthcare, residential, and commercial properties. Established in 1983, the company has built a diversified portfolio worth approximately €6.2 billion, spanning Belgium, France, the Netherlands, Germany, Spain, Finland, Ireland, Italy, and the United Kingdom. Focused on addressing societal needs, Cofinimmo prioritizes high-quality, sustainable spaces for healthcare, living, and working environments. Its healthcare portfolio, valued at €4.6 billion, underscores its commitment to this sector. Operating with 155 employees across offices in Brussels, Paris, Breda, Frankfurt, and Madrid, the company adheres to stringent corporate governance and sustainability standards. Listed on Euronext Brussels (BEL20), Cofinimmo benefits from REIT status in Belgium (RREC), France (SIIC), and the Netherlands (FBI), ensuring tax efficiency and regulatory compliance under the supervision of the Financial Services and Markets Authority (FSMA).
Over the next three months, Cofinimmos stock is expected to show moderate growth, supported by strong fundamentals and technical indicators. The stock is trading above its 20, 50, and 200-day moving averages (SMA 20: 61.52, SMA 50: 60.06, SMA 200: 59.32), signaling bullish momentum. The average true range (ATR) of 1.60 suggests low volatility, indicating stable price movements. Fundamentally, the companys forward P/E of 10.58 signals potential undervaluation compared to its trailing P/E of 38.76. However, the price-to-book (P/B) ratio of 0.71 and price-to-sales (P/S) of 6.41 suggest a balanced valuation. With a market cap of €2.509 billion and return on equity (RoE) of 1.81%, Cofinimmo is positioned for steady performance in the near term, driven by its diversified portfolio and focus on sustainable real estate.
Additional Sources for COFB Stock
COFB Stock Overview
Market Cap in USD | 2,838m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Diversified REITs |
IPO / Inception |
COFB Stock Ratings
Growth Rating | -35.4 |
Fundamental | - |
Dividend Rating | 82.4 |
Rel. Strength | 14.2 |
Analysts | - |
Fair Price Momentum | 89.92 EUR |
Fair Price DCF | - |
COFB Dividends
Dividend Yield 12m | 17.96% |
Yield on Cost 5y | 13.56% |
Annual Growth 5y | 2.06% |
Payout Consistency | 93.7% |
COFB Growth Ratios
Growth Correlation 3m | 81.4% |
Growth Correlation 12m | -16.9% |
Growth Correlation 5y | -82.6% |
CAGR 5y | -2.98% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | 0.23 |
Alpha | 25.33 |
Beta | 0.089 |
Volatility | 25.82% |
Current Volume | 121.8k |
Average Volume 20d | 132k |
As of May 08, 2025, the stock is trading at EUR 78.35 with a total of 121,818 shares traded.
Over the past week, the price has changed by +11.13%, over one month by +35.20%, over three months by +43.11% and over the past year by +31.28%.
Probably not. Based on ValueRay Analyses, Cofinimmo (BR:COFB) is currently (May 2025) not a good stock to buy. It has a ValueRay Growth Rating of -35.35 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COFB as of May 2025 is 89.92. This means that COFB is currently undervalued and has a potential upside of +14.77% (Margin of Safety).
Cofinimmo has no consensus analysts rating.
According to ValueRays Forecast Model, COFB Cofinimmo will be worth about 97.1 in May 2026. The stock is currently trading at 78.35. This means that the stock has a potential upside of +23.96%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 65.2 | -16.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 97.1 | 24% |